Form 8-K - Current report:
SEC Accession No. 0001558370-21-012312
Filing Date
2021-09-08
Accepted
2021-09-08 16:21:13
Documents
12
Period of Report
2021-09-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K edit-20210903x8k.htm   iXBRL 8-K 34673
  Complete submission text file 0001558370-21-012312.txt   153016

Data Files

Seq Description Document Type Size
2 EX-101.SCH edit-20210903.xsd EX-101.SCH 2997
3 EX-101.LAB edit-20210903_lab.xml EX-101.LAB 15382
4 EX-101.PRE edit-20210903_pre.xml EX-101.PRE 9973
5 EXTRACTED XBRL INSTANCE DOCUMENT edit-20210903x8k_htm.xml XML 4632
Mailing Address 11 HURLEY ST. CAMBRIDGE MA 02141
Business Address 11 HURLEY ST. CAMBRIDGE MA 02141 617-401-9000
Editas Medicine, Inc. (Filer) CIK: 0001650664 (see all company filings)

EIN.: 464097528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37687 | Film No.: 211242359
SIC: 2836 Biological Products, (No Diagnostic Substances)